Papers

34 results
Aspiration thrombectomy in ST-Elevation myocardial infarction: Further insights from a network meta-analysis of randomized trials.
Gajulapalli RD, Kanmanthareddy A, Balakumaran K, Hong H, Bolen S, Kondapaneni M, Pasala TKR - Indian heart journal, April 19, 2021 0 citations
P
ST-elevation myocardial infarction (STEMI) patients
I/C
Aspiration or manual thrombectomy (AT), Conventional PCI (cPCI)
O
Major adverse cardiac events (MACE), mortality, myocardial infarction (MI), target vessel revascularization (TVR), stent thrombosis (ST), stroke, left ventricular ejection fraction (LVEF), myocardial blush grade (MBG), ST segment resolution (STR), and infarct size
Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI: A Systematic Review and Meta-analysis.
Alyamani M, Campbell S, Navarese E, Welsh RC, Bainey KR - The Canadian journal of cardiology, August 03, 2020 18 citations
P
patients with ST-elevation myocardial infarction undergoing primary PCI
I/C
IC thrombolytic agents, IC placebo
O
Post-PCI thrombolysis in myocardial infarction (TIMI) flow grade 2/3, Complete ST-segment resolution, In-hospital major adverse cardiac events, Bleeding (TIMI major, TIMI minor, and Bleeding Academic Research Consortium [BARC] 3-5 bleeds)
Complete Versus Culprit-Only Revascularization in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
Salih M, Ibrahim AM, Al-Akchar M, Bhattarai M, Koester C, Ayan M, Hafiz AM - Cardiovascular revascularization medicine : including molecular interventions, June 24, 2020 1 citations
P
patients with ST elevation myocardial infarction (STEMI)
I/C
complete revascularization, culprit-only revascularization
O
major adverse cardiovascular events, revascularization, reinfarction
P
patients with ST-segment elevation myocardial infarction (STEMI)
I/C
abciximab, with or without abciximab
O
all-cause death, reinfarction, revascularization, minor bleeding, thrombocytopenia
Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.
Saito T, Fujisaki T, Aikawa T, Kampaktsis PN, Malik A, Briasoulis A, Takagi H, Wiley J, Slipczuk L, Kuno T - International journal of cardiology, July 12, 2023 2 citations
P
STEMI, NSTE-ACS
I/C
dual antiplatelet therapy (DAPT), standard DAPT (12 months) with clopidogrel or potent P2Y
O
NACE
Meta-Analysis Comparing Same-Sitting and Staged Percutaneous Coronary Intervention of Non-Culprit Artery for ST-Elevation Myocardial Infarction with Multivessel Coronary Disease.
Ueyama H, Kuno T, Yasumura K, Vengrenyuk Y, Takagi H, Barman N, Suleman J, Banning AS, Boxma-de Klerk BM, Smits PC, Kini A, Sharma SK - The American journal of cardiology, May 21, 2021 2 citations
P
patients with multivessel coronary disease and ST-segment elevation myocardial infarction (STEMI)
I/C
complete revascularization (CR), culprit-only intervention
O
major adverse cardiovascular events (MACE), cardiovascular death, myocardial infarction, and revascularization
Meta-Analysis of Optimal Revascularization Strategy for Patients With ST-Segment Elevation Myocardial Infarction and Multi-Vessel Coronary Artery Disease.
Shah R, Nayyar M, Le FK, Labroo A, Davis DA, Brilakis ES, Kandzari DE - The American journal of cardiology, June 17, 2020 2 citations
P
patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease
I/C
complete revascularization (CR), infarct-related artery-only revascularization (IRA-OR)
O
cardiovascular (CV) mortality, myocardial infarction (MI), recurrent revascularization
Strength training has antidepressant effects in people with depression or depressive symptoms but no other severe diseases: A systematic review with meta-analysis.
Rossi FE, Dos Santos GG, Rossi PAQ, Stubbs B, Barreto Schuch F, Neves LM - Psychiatry research, March 02, 2024 1 citations
P
people with a diagnosis of depression or subthreshold depressive symptoms
I/C
strength training (ST), no other severe disease
O
antidepressant effects
Efficiency of High-Flow Nasal Cannula on Pulmonary Rehabilitation in COPD Patients: A Meta-Analysis.
Fu C, Liu X, Zhu Q, Wu X, Hao S, Xie L, Li S - BioMed research international, October 22, 2020 9 citations
P
COPD patients
I/C
High-flow nasal cannula (HFNC), Conventional oxygen therapy (COT), Noninvasive ventilation (NIV)
O
Respiratory rate, Forced expiratory volume in one second (FEV1), Tidal volume, Oxygen partial pressure, Total score of St. George's respiratory questionnaire, Six-minute walk test, Exercise endurance time
P
patients with acute myocardial infarction (AMI), healthy controls, symptomatic controls
I/C
Mir-133a analysis, healthy vs. symptomatic controls
O
diagnostic performance, area under the summary receiver operator characteristic curve (AUC)
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.